IL-6 may be considered a potentially useful biomarker for influenza testing, and its significance as a biomarker may be further underscored by its associated rise in patients with encephalopathy (Aiba et al., 2001; Oh et al., 2002; Chiaretti et al., 2013). This evidence concerns the gene IL6 and Encephalopathy.